Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Revista Clínica de Medicina de Familia
versão On-line ISSN 2386-8201versão impressa ISSN 1699-695X
Resumo
DIAZ-GRAVALOS, Gabriel J. et al. Suitability of inhaled therapy in patients diagnosed with chronic obstructive pulmonary disease (COPD). Rev Clin Med Fam [online]. 2013, vol.6, n.1, pp.4-9. ISSN 2386-8201. https://dx.doi.org/10.4321/S1699-695X2013000100002.
Objective: To assess the compliance of inhaled therapy in patients diagnosed with chronic obstructive lung disease to clinical guidelines (GOLD). Design: Indication/prescription cross-sectional observational study. Location: Primary care in the province of Orense. Participants: All cases of COPD included in the register for 28 chronic patients in 9 health centres in the province of Orense. Main Surveyed Data. The following were determined: age, sex, spirometric data, adjustment of diagnosis based on spirometric results, and inhaled drug therapy (long-acting anticholinergics, inhaled corticosteroids, long-acting beta-2 and short-acting beta-2). Results: 297 cases (77.7%) were male, with an average age of 77.0 years. The FEV1/ FVC ratio was registered in 174 (45.5%) patients. It was lower than 0.7 in 138 cases (36.1%) and FEV1 appeared in 125 cases (90.6%). 71 patients (56.8%) were classified as severe or very severe. The treatment was in accordance with recommendations in 26,4% of the cases. In 19.2% it was incorrect by default and in 54.4%, through over-medication, related primarily to the use of inhaled corticosteroids, which were correctly indicated in 9% of cases. There were no differences in the use of associated drugs based on the severity of the COPD. Conclusions: In COPD therapy with inhaled drugs, there is a low level of compliance with criteria recommended in the main clinical practice guidelines, especially regarding the use of corticosteroids.
Palavras-chave : Chronic obstructive pulmonary disease/therapy; Bronchodilators; glucocorticoids; Adhesion to guidelines; Quality of healthcare; Primary healthcare.